HemoTypeSCTM Point-of-care Testing as a Screening Tool for Sickle Cell Disease among Newborns in Ilesa, Nigeria. NIGERIAN JOURNAL OF PAEDIATRICS, [S. l.], v. 53, n. 1, p. 20–27, 2026. DOI: 10.63270/njp.v53i1.2000045. Disponível em: https://njpaediatrics.com/index.php/njp/article/view/1236.. Acesso em: 24 jun. 2026.